A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
about
Olanzapine versus other atypical antipsychotics for schizophreniaAmisulpride versus other atypical antipsychotics for schizophreniaAlmost all antipsychotics result in weight gain: a meta-analysis.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatioThe SWITCH study: rationale and design of the trial.Update on the management of symptoms in schizophrenia: focus on amisulpride.Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity?A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis
P2860
Q24236545-63E1502F-1A80-49C7-83DE-494B47D49C24Q24240433-7CFF7DD0-33A2-4F84-B4BE-2FEDC45D5A2BQ34661499-105C99F9-CF6A-4122-AA1D-CC727399CE3FQ37865505-E9418070-B2A7-40D9-A755-E2F8127FF4D0Q38042478-CF2B4459-540B-4B63-BD99-346CF5EC4A1CQ38395937-476C024C-E73F-4416-98DC-FED060580BC7Q38979325-41FDD8F5-4F2F-493D-B08B-8CE9C72AF15EQ41529086-E81BF991-8BB6-4DE5-B7F2-4C88FF2486CBQ42326625-D93F0BE3-C372-4DCB-A352-69116F63D122Q48381074-4270A7E7-FE56-4757-9626-822BAD6AC783Q58763260-43B58248-CC15-4EF7-B691-E03FF4CE0FD2
P2860
A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A double-blind randomised comp ...... renia and comorbid depression.
@en
A double-blind randomised comp ...... renia and comorbid depression.
@nl
type
label
A double-blind randomised comp ...... renia and comorbid depression.
@en
A double-blind randomised comp ...... renia and comorbid depression.
@nl
prefLabel
A double-blind randomised comp ...... renia and comorbid depression.
@en
A double-blind randomised comp ...... renia and comorbid depression.
@nl
P1433
P1476
A double-blind randomised comp ...... renia and comorbid depression.
@en
P2093
P304
P356
10.1016/J.EURPSY.2006.09.003
P407
P577
2006-11-20T00:00:00Z